Further studies will be required to address the impact of IFN-λ3, as well as IFNL3 genetic variation on ILD severity and progression in cohorts of incident patients followed prospectively with multiple HRCTs, and to clarify the functional mechanisms of this genetic association. This evidence concerns the gene IFNL3 and interstitial lung disease.